Bioengineered Artificial Skin Market Growth Accelerated by Increasing Incidents of Burn Injuries and Skin Defects
Bioengineered artificial skin products have gained traction over the past few years owing to their ability regenerate and replace damaged or defective skin tissues. These products are developed using cultured tissues obtained from autologous skin cells of patients. This process aids quick regeneration of functional tissues similar to the skin, preventing fluid loss, infection, and scarring. The global bioengineered artificial skin market demand has been fuelled by increasing incidence of burns, skin defects due to injuries, and genetic disorders.
The global bioengineered artificial skin market is estimated
to be valued at US$ 1.2 billion in 2023 and is expected to exhibit a CAGR of
16% over the forecast period 2023 to 2028, as highlighted in a new report
published by Coherent Market Insights.
Market key trends:
The increasing cases of burn injuries and skin defects has been a prominent
driver for the bioengineered
artificial skin market growth over the past few years. According to the
American Burn Association, there were over 450,000 burn injuries that required
medical attention in 2021 alone in the United States. Moreover, genetic skin
disorders such as Epidermolysis bullosa have also increased globally over time.
Advancements in tissue engineering techniques aided by the use of stem cells
and biomaterials have enabled production of bioengineered skin grafts similar
to native skin tissues and accelerated the healing process. This has driven the
demand for these products across hospitals and burn care centers.
Segment
Analysis
The global bioengineered artificial skin market is dominated by the burn care
segment, accounting for over 40% share in 2023. Burn care involves covering
burned parts of the skin with artificial skin temporarily until the burned skin
heals or gets replaced by healthy skin through skin grafting. Artificial skin
acts as an effective barrier, preventing chances of infection and further
damage to burned skin.
Key Takeaways
The global bioengineered artificial skin market is expected to witness high
growth during the forecast period of 2023 to 2028 on account of rising
incidence of burns, trauma injuries, and chronic wounds globally.
Key players: Key players operating in the bioengineered artificial skin market are MiMedx, Smith & Nephew, Integra LifeSciences Corporation, Organogenesis, Mallinckrodt, Tissue Regenix, Nuo Therapeutics, Stratatech Corporation, and Mylan. MiMedx dominates the global market with over 30% share owing to its extensive Artificial Skin product portfolio for treating severe burns and wounds.
Comments
Post a Comment